A Boston Scientific (NYSE:BSX) executive said today that the company enrolled the first patients in a new pulsed field ...
Boston Scientific President of Vascular Therapies, Cat Jennings.\ [Image from LinkedIn] Boston Scientific (NYSE:BSX) ...
Lately, it may feel like you can't go a day without seeing an ad on TV or online about erectile dysfunction (ED). Despite the ...
In May 2026, Boston Scientific invested $1.5 billion in MiRus, the developer of the novel, balloon-expandable Siegel transcatheter aortic valve replacement (TAVR) implant featuring a proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results